<p>Prime Medicine 宣布领导层变动：艾伦·雷恩博士被任命为首席执行官，基思·戈特斯迪纳辞职</p>
<p>Prime Medicine Inc. 宣布其管理团队发生变动。基思·戈特斯迪纳医学博士立即辞去首席执行官及董事会成员职务。艾伦·雷恩医学博士，之前担任公司的首席财务官，已被任命为新首席执行官，并将加入董事会。现任董事会成员杰夫·马拉佐被任命为执行主席。戈特斯迪纳博士将在公司担任顾问，任期为一年。</p>

PRME

<p>Prime Medicine Inc. 宣布了领导层的变动，艾伦·雷恩博士被任命为新任首席执行官，接替立即辞职的基思·戈特斯迪纳。雷恩博士此前担任首席财务官，同时将加入董事会。杰夫·马拉佐被任命为执行主席。戈特斯迪纳将继续担任顾问，任期为一年</p>

<p>Prime Medicine Announces Leadership Transition: Dr. Allan Reine Appointed CEO as Keith Gottesdiener Steps Down</p>
<div class="lb-trans"><p>Prime Medicine 宣布领导层变动：艾伦·雷恩博士被任命为首席执行官，基思·戈特斯迪纳辞职</p>
</div><p>Prime Medicine Inc. has announced a change in its management team. Keith Gottesdiener, M.D., has stepped down as CEO and member of the Board of Directors, effective immediately. Allan Reine, M.D., previously the company's CFO, has been appointed as the new CEO and will join the Board of Directors. Jeff Marrazzo, currently a Board member, has been named Executive Chair. Dr. Gottesdiener will remain with the company as a consultant for one year.</p>
<div class="lb-trans"><p>Prime Medicine Inc. 宣布其管理团队发生变动。基思·戈特斯迪纳医学博士立即辞去首席执行官及董事会成员职务。艾伦·雷恩医学博士，之前担任公司的首席财务官，已被任命为新首席执行官，并将加入董事会。现任董事会成员杰夫·马拉佐被任命为执行主席。戈特斯迪纳博士将在公司担任顾问，任期为一年。</p>
</div>

Prime Medicine 宣布领导层过渡：Allan Reine 博士被任命为首席执行官，Keith Gottesdiener 卸任